WO2004024667A1 - 2−(ヒドロキシメチル)シクロプロパンカルボン酸化合物の製造方法 - Google Patents
2−(ヒドロキシメチル)シクロプロパンカルボン酸化合物の製造方法 Download PDFInfo
- Publication number
- WO2004024667A1 WO2004024667A1 PCT/JP2003/011330 JP0311330W WO2004024667A1 WO 2004024667 A1 WO2004024667 A1 WO 2004024667A1 JP 0311330 W JP0311330 W JP 0311330W WO 2004024667 A1 WO2004024667 A1 WO 2004024667A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methyl
- group
- butyl
- methoxyphenyl
- tert
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/353—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Definitions
- the present invention relates to a method for producing a 2- (hydroxymethyl) cyclopropanecarponic acid compound useful as an intermediate for producing a formylcyclopropane-potassium sulfonic acid compound used for the synthesis of a chrysanthemic acid derivative or the like.
- a method for producing methyl is disclosed.
- Scheme 1 described in Tetrahedron, 2001, p. 57, 6086 a diester compound in which the hydroxyl group of 2- (hydroxymethyl) -1,3-dimethylcyclopropanecarboxylate is acetylated is used under basic conditions. And a method for selectively hydrolyzing the same.
- a 2- (hydroxymethyl) cyclopropanecarboxylic acid compound represented by the following formula (2) can be industrially advantageously obtained.
- the present invention relates to a catalyst selected from the group consisting of a ruthenium catalyst, a cobalt catalyst, a rhodium catalyst, a nickel catalyst, a palladium catalyst, and a platinum catalyst, the formula (1):
- R 1 represents a hydrogen atom, a linear, branched or cyclic alkyl group, or a substituted or unsubstituted aryl group
- R 2 and R 3 are the same or different and each represent a hydrogen atom Or a methyl group
- R 4 represents a C 1-2 alkyl group substituted with at least one group selected from a substituted aryl group and an unsubstituted aryl group. Equation (2) featuring reacting the body:
- examples of the linear, branched or cyclic alkyl group represented by R 1 include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, and an n-butyl group.
- Examples of the unsubstituted aryl group represented by R 1 include, for example, a phenyl group and a naphthyl group.
- Examples of the substituted aryl group include the unsubstituted aryl group.
- the above-mentioned alkyl group preferably, a CI-4 alkyl group such as a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group and a tert-butyl group
- a fluorine atom for example, an alkoxy group such as a methoxy group or an ethoxy group, for example, an alkoxyalkyl group such as a methoxymethyl group, for example, an aryl group such as a phenyl group or a naphthyl group, an aryloxy group, for example, a phenoxy
- R 1 is preferably a linear, branched or cyclic alkyl group, and may be a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, or a tert group.
- a C14 alkyl group such as a butyl group is more preferred.
- an unsubstituted C 12 alkyl group (preferably methyl group) substituted with at least one group selected from a substituted aryl group and an unsubstituted aryl group represented by R 4 .
- the aryl group include a phenyl group and a naphthyl group (preferably a phenyl group).
- the substituted aryl group include an alkyl group (for example, a methyl group, an ethyl group, a propyl group, and a butyl group).
- the group is exemplified.
- a benzyl group a diphenylmethyl group, a trityl group, a phenethyl group (preferably a 1-phenethyl group), a naphthylmethyl group, a 4-methoxybenzyl group, a 2,4-dimethoxybenzyl group, Examples thereof include a 4-phenylpentyl group, a (4-methoxyphenyl) diphenylmethyl group, a di (4-methoxyphenyl) phenylmethyl group, and a tri (4-methoxyphenyl) methyl group.
- a benzyl group is preferred.
- the compound represented by the formula (1) includes — a group represented by C ⁇ 2 R 1 and a group represented by one CH 2 OR 4 which are opposite to the cis-form on the same side of the cyclopropane ring plane. Although there is a trans-form on the opposite side,
- the compound represented by the formula (1) has an asymmetric carbon atom and thus has an optical isomer.
- any one of the optical isomers may be used, A mixture of two or more optical isomers in any proportion may be used.
- the compound represented by the formula (1) can be produced, for example, by a known method in which a corresponding olefin compound and a diazoacetate compound are reacted in the presence of a metal catalyst (for example, Tetrahedron, 2001, 57, 6083-6088 etc.).
- a metal catalyst for example, Tetrahedron, 2001, 57, 6083-6088 etc.
- Examples of the compound represented by the formula (1) include 2- (benzyloxymethyl) cyclopropanecarboxylic acid, 2-[(4-methoxybenzyloxy) methyl] cyclopropanecarboxylic acid, and 2-((2,4- Dimethoxybenzyloxy) methyl] cyclopropanecarboxylic acid,
- the catalyst selected from the group consisting of a ruthenium catalyst, a cobalt catalyst, a rhodium catalyst, a nickel catalyst, a palladium catalyst, and a platinum catalyst used in the method of the present invention includes ruthenium, cobalt, rhodium, nickel, palladium, and platinum metal or a compound thereof May be a heterogeneous catalyst supported on a carrier such as activated carbon, alumina or silica, or a homogeneous catalyst in which various ligands are coordinated to these metals or a compound thereof. There may be.
- Examples of the ruthenium catalyst include ruthenium Z alumina, ruthenium Z carbon, and chlorotris (triphenylphosphine) ruthenium, and examples of the copartite catalyst include Raney cobalt.
- Examples of the rhodium catalyst include rhodium / alumina, rhodium-no-carbon, and rhodium chlorotris (triphenylphosphine).
- Examples of the nickel catalyst include Raney nickel, nickel z-carbon, nickel Z silica-alumina, and tetrakis (triphenyl). Phosphine) nickel, bis (cyclooctagene) nickel, and the like.
- Examples of the palladium catalyst include palladium / carbon, palladium alumina, tetrakis (triphenylphosphine) palladium, tris (dibenzylideneacetone) dipalladium, palladium hydroxide carbon, and the like.
- Examples of the platinum catalyst include platinum. Z carbon, platinum Z alumina, tetrakis (Trif Phenylphosphine) platinum, bis (cyclooctagene) platinum and the like.
- a commercially available product may be used as it is, or a catalyst prepared by a known method may be used.
- the amount of the catalyst to be used may be generally a catalytic amount, and may be in the range of about 0.001 to 1 mol, per 1 mol of the compound represented by the formula (1).
- hydrogen donor for example, hydrogen '() is preferable.
- hydrogen donor formic acid, ammonium formate, cyclohexene, cyclohexadiene, isopropyl alcohol, etc. are exemplified. Of the body, formic acid is preferred.
- a palladium catalyst is preferable, and among them, palladium Z carbon is preferable.
- a nickel catalyst, particularly rac-nickel is exemplified as a preferable catalyst, and is suitably used together with hydrogen.
- the hydrogen donor may be added to the reaction system as it is, or may be used by dissolving or suspending it in a solvent described below, for example. Such hydrogen donors may be used alone or in combination.
- the amount of the hydrogen donor to be used is generally 1 mol or more per 1 mol of the compound represented by the formula (1), and the upper limit is not particularly limited.
- This reaction is usually carried out by contacting and mixing a catalyst, a compound represented by the formula (1) and a hydrogen donor, and the mixing order is not particularly limited. Further, the reaction may be performed under normal pressure conditions or may be performed under pressurized conditions. This reaction may be carried out without a solvent or in a solvent.
- the solvent is not particularly limited as long as it does not inhibit the reaction.
- alcohol solvents such as methanol, ethanol and isopropyl alcohol, or aromatic hydrocarbon solvents such as toluene, xylene and mesitylene, for example, dichloromethane, Halogenated hydrocarbon solvents such as chloroform, carbon tetrachloride, 1,2-dichloroethane, etc.
- ether solvents such as getyl ether, diisopropyl ether, methyl tert-butyl ether, inert solvents such as water, and the like.
- a mixture of solvents is exemplified, and the amount used is not particularly limited.
- the reaction temperature is usually about 0 ° C to 100 ° C. 03 011330
- the catalyst When a heterogeneous catalyst is used as the catalyst, for example, the catalyst is filtered off from the reaction solution and then concentrated to obtain the desired 2- (hydroxymethyl) represented by the formula (2). )
- the cyclopropane ruponic acid compound can be taken out.
- the 2- (hydroxymethyl) cyclopropanecarboxylic acid compound represented by the formula (2) can be obtained by, for example, subjecting the reaction solution to a distillation treatment.
- the 21 (hydroxymethyl) cyclopropanecarboxylic acid compound represented by the formula (2) taken out may be further purified by a conventional purification means such as, for example, distillation and column chromatography.
- the compound represented by the formula (2) in which the ratio of the cis-isomer / trans-isomer is maintained.
- 2- (Hydroxymethyl) cyclopropanecarboxylic acid compound is obtained, and when an optically active substance is used as the compound represented by the formula (1), the compound is represented by the formula (2) in which the stereo is retained.
- An optically active isomer of 2- (hydroxymethyl) cyclopropane sulfonic acid compound was obtained.
- the 2- (hydroxymethyl) cyclopropane carboxylic acid compound represented by the formula (2) thus obtained includes, for example, 2- (hydroxymethyl) cyclopropanecarboxylic acid, 2- (hydroxymethyl) cyclopropanecarboxylic acid methyl, -(Hydroxymethyl) cyclopropane ethyl propane, tert-butyl 2- (hydroxymethyl) cyclopropanecarbonate, 2- (hydroxymethyl) cyclopropane cyclohexyl ruponate, 2- (hydroxymethyl) cyclopropane Menthyl carboxylate, 2- (hydroxymethyl) cyclopropane methyl ester
- the 2- (hydroxymethyl) cyclopropanecarboxylic acid compound represented by the formula (2) thus obtained can be further reacted with an oxidizing agent to produce a corresponding 2-formylcyclopropane sulfonic acid compound.
- the oxidizing agent include oxidizing agents used in Swern oxidation (for example, tetrahedron, 2001, 57, 6083—6088) and pyridinium chromate (for example, tetrahedron: Asy R. etry, 1995, 6, 683-384) can be exemplified, but the method described in International Application (PCT / JP03 / 08555) is exemplified as a preferable oxidation reaction.
- PCT / JP03 / 08555 exemplified as a preferable oxidation reaction.
- Example 1 In a 20 OmL Schlenk tube, 2- (benzyloxymethyl) -3,3-dimethylcyclofide. 2.6 g of mouth ethyl carboxylate, 10 OmL of a 4.4% by weight formic acid / methanol solution and 2.6 g of 10% by weight palladium / carbon were charged and stirred at room temperature for 7 hours to react. Thereafter, the reaction solution was filtered through celite to remove the catalyst, and the obtained filtrate was concentrated to give a colorless transparent oil, ethyl 2- (hydroxymethyl) -3,3-dimethylcyclopropanecarboxylate 1.7 g. Yield: 98%.
- Example 2 Example 2
- This liquid separation operation was repeated three times. 127 g of 35% hydrochloric acid and 111 ml of toluene were added to the obtained aqueous solution, and the mixture was separated to give a toluene solution containing crude 2_ (benzyloxymethyl) -3,3-dimethylcyclopropanecarboxylic acid. This liquid separation operation was repeated three times. The obtained toluene solution was washed three times with 11 lml of water and then concentrated to obtain 96.9 g of 2- (benzyloxymethyl) -1,3-dimethylcyclopropanecarboxylic acid. Yield 100%.
- An acid compound can be obtained industrially advantageously.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003261948A AU2003261948A1 (en) | 2002-09-10 | 2003-09-05 | Process for production of 2-(hydroxymethyl)cyclo- propanecarboxylic acids |
US10/527,267 US20050288526A1 (en) | 2002-09-10 | 2003-09-05 | Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids |
EP03795291A EP1538141A4 (en) | 2002-09-10 | 2003-09-05 | PROCESS FOR THE PREPARATION OF 2- (HYDROXYMETHYL) CYCLOPROPANCARBONSURE |
IL167058A IL167058A (en) | 2002-09-10 | 2005-02-22 | Process for production of a 2-(hydroxymethyl) cyclopropanecarboxylic compound |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-263700 | 2002-09-10 | ||
JP2002263700 | 2002-09-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004024667A1 true WO2004024667A1 (ja) | 2004-03-25 |
Family
ID=31986461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/011330 WO2004024667A1 (ja) | 2002-09-10 | 2003-09-05 | 2−(ヒドロキシメチル)シクロプロパンカルボン酸化合物の製造方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050288526A1 (ja) |
EP (1) | EP1538141A4 (ja) |
KR (1) | KR20050049487A (ja) |
CN (1) | CN1681767A (ja) |
AU (1) | AU2003261948A1 (ja) |
IL (1) | IL167058A (ja) |
WO (1) | WO2004024667A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102952011B (zh) * | 2011-08-24 | 2015-02-18 | 南通雅本化学有限公司 | 蒈醛酸内酯的合成方法 |
CN104163759B (zh) * | 2011-08-24 | 2016-05-04 | 南通雅本化学有限公司 | 卡龙酸、卡龙酸酐的新合成方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2376120A1 (fr) * | 1976-12-30 | 1978-07-28 | Roussel Uclaf | Procede de preparation d'esters d'alcoyle inferieur d'acides cis ou trans 3-formyl cyclopropane 1-carboxyliques 2,2-disubstitues racemiques |
EP0022208A1 (de) * | 1979-07-05 | 1981-01-14 | Bayer Ag | Verfahren zur Herstellung von 2-Formyl-3,3-dimethyl-cyclopropan-1-carbonsäureestern |
-
2003
- 2003-09-05 WO PCT/JP2003/011330 patent/WO2004024667A1/ja active Application Filing
- 2003-09-05 CN CNA038215179A patent/CN1681767A/zh active Pending
- 2003-09-05 US US10/527,267 patent/US20050288526A1/en not_active Abandoned
- 2003-09-05 AU AU2003261948A patent/AU2003261948A1/en not_active Abandoned
- 2003-09-05 KR KR1020057004016A patent/KR20050049487A/ko not_active Application Discontinuation
- 2003-09-05 EP EP03795291A patent/EP1538141A4/en not_active Withdrawn
-
2005
- 2005-02-22 IL IL167058A patent/IL167058A/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2376120A1 (fr) * | 1976-12-30 | 1978-07-28 | Roussel Uclaf | Procede de preparation d'esters d'alcoyle inferieur d'acides cis ou trans 3-formyl cyclopropane 1-carboxyliques 2,2-disubstitues racemiques |
EP0022208A1 (de) * | 1979-07-05 | 1981-01-14 | Bayer Ag | Verfahren zur Herstellung von 2-Formyl-3,3-dimethyl-cyclopropan-1-carbonsäureestern |
Non-Patent Citations (3)
Title |
---|
BURGESS KEVIN ET AL.: "Large Scale Syntheses of N-Protected 2,3-Methanomethionine Stereoisomers.", SYNTHESIS, no. 12, December 1996 (1996-12-01), pages 1463 - 1467, XP002974914 * |
BURGESS KEVIN ET AL.: "Synthesis of a Valuable Cyclopropyl Chiron for Preparations of 2,3-Methanoamino Acids.", J.ORG.CHEM., vol. 58, no. 14, 1993, pages 3767 - 3768, XP002060010 * |
See also references of EP1538141A4 * |
Also Published As
Publication number | Publication date |
---|---|
IL167058A (en) | 2011-08-31 |
KR20050049487A (ko) | 2005-05-25 |
EP1538141A1 (en) | 2005-06-08 |
US20050288526A1 (en) | 2005-12-29 |
EP1538141A4 (en) | 2009-07-15 |
AU2003261948A1 (en) | 2004-04-30 |
CN1681767A (zh) | 2005-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009510005A (ja) | 分子内プリンス反応および該反応に適する触媒 | |
JPH09169685A (ja) | 第1級又は第2級アルコールの酸化方法 | |
EP3164408B1 (fr) | Nouveau procédé de fabrication du (e,z)-7,9 dodécandiényl-1-acétate | |
JPH05331128A (ja) | (R)−(−)−4−シアノ−3−ヒドロキシ酪酸t−ブチルエステル及びその製造方法 | |
JP3053872B2 (ja) | (+)−(1r)−シス−3−オキソ−2−ペンチル−1−シクロペンタン酢酸の製造法 | |
CN109956850B (zh) | 3,7-二甲基-7-辛烯醇和3,7-二甲基-7-辛烯基羧酸酯化合物的生产方法 | |
WO2004024667A1 (ja) | 2−(ヒドロキシメチル)シクロプロパンカルボン酸化合物の製造方法 | |
JP5622019B2 (ja) | アミノアルコール誘導体塩構造を有する不斉有機分子触媒及び該不斉有機分子触媒を用いた光学活性化合物の製造方法 | |
US5523437A (en) | Tertiary phosphine compound and transition metal complex comprising the same as ligand | |
JPS5820948B2 (ja) | デルタ 4 ,デルタ 8− トランスフアルネシルサクサン マタハ ソノエステルルイ ノ セイゾウホウ | |
JP4345413B2 (ja) | 2−(ヒドロキシメチル)シクロプロパンカルボン酸化合物の製造方法 | |
US5087762A (en) | Process for producing vitamin a aldehyde | |
JP3756266B2 (ja) | 光学活性α−イオノンの製造方法 | |
WO2005080299A1 (fr) | Nouveaux composes chiraux derives d'une diamine ou d'un aminoalcool, monosulfonyles et carbonyles porteurs d'un groupe pyrrolidinyle, leur preparation et leurs applications en catalyse asymetrique | |
US20050054877A1 (en) | Enantiomerically selective cyclopropanation | |
JP3991455B2 (ja) | 光学活性な菊酸エステルの製造法 | |
JP4860510B2 (ja) | β位に不斉点を有するカルボン酸の製造及び求核剤 | |
JP2002069026A (ja) | (e)−3−メチル−2−シクロペンタデセノンの製造法 | |
JP3072314B2 (ja) | γ−アルキリデン−γ−ブチロラクトン誘導体の製造方法 | |
US6011169A (en) | Process for producing optically active cyclopropanecaboxylic acid esters | |
KR100365526B1 (ko) | 바이시클로[3.3.1]노난 구조 화합물의 제조방법 | |
JP3171919B2 (ja) | 3−(2,2,6−トリメチルシクロヘキサン−1−イル)−2−プロペン−1−アールの製造方法及びその中間体 | |
FR3094368A1 (fr) | Procédé de préparation de composés 1,2-endoperoxyde | |
JPH09100285A (ja) | 光学活性な5−ヒドロキシ−3−オキソ−6−ヘプチン酸エステル誘導体の製造方法 | |
JPH078827B2 (ja) | α,β‐不飽和アルデヒドの製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 167058 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10527267 Country of ref document: US Ref document number: 1020057004016 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038215179 Country of ref document: CN Ref document number: 2003795291 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 0560/CHENP/2005 Country of ref document: IN Ref document number: 560/CHENP/2005 Country of ref document: IN |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057004016 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2003795291 Country of ref document: EP |